Department of Economics, University of Helsinki, Arkadiankatu 7, P.O. Box 17, 00014, Helsinki, Finland.
VATT Institute for Economic Research, Arkadiankatu 7, P.O. Box 1279, 00101, Helsinki, Finland.
Nat Commun. 2022 Mar 4;13(1):1162. doi: 10.1038/s41467-022-28825-4.
Mass vaccination is effective in reducing SARS-CoV-2 infections among vaccinated individuals. However, it remains unclear how effectively COVID-19 vaccines prevent people from spreading the virus to their close contacts. Using nationwide administrative datasets on SARS-CoV-2 infections, vaccination records, demographics, and unique household IDs, we conducted an observational cohort study to estimate the direct and indirect effectiveness of mRNA-based COVID-19 vaccines in reducing infections among vaccinated healthcare workers and their unvaccinated household members. Our estimates for adults imply indirect effectiveness of 39.1% (95% CI: -7.1% to 65.3%) two weeks and 39.0% (95% CI: 18.9% to 54.0%) eight weeks after the second dose. We find that the indirect effect of mRNA-based COVID-19 vaccines within households is smaller for unvaccinated children than for adults and statistically insignificant. Here, we show that mRNA-based COVID-19 vaccines are associated with a reduction in SARS-CoV-2 infections not only among vaccinated individuals but also among unvaccinated adult household members in a real-world setting.
大规模疫苗接种可有效减少已接种人群的 SARS-CoV-2 感染。然而,目前尚不清楚 COVID-19 疫苗在多大程度上能防止人们将病毒传播给其密切接触者。我们利用全国性的 SARS-CoV-2 感染、疫苗接种记录、人口统计学和独特家庭 ID 的行政数据集,开展了一项观察性队列研究,以估计基于 mRNA 的 COVID-19 疫苗在减少接种医护人员及其未接种家庭接触者感染方面的直接和间接效果。我们对成年人的估计表明,第二剂疫苗接种后两周和八周的间接效果分别为 39.1%(95%CI:-7.1%至 65.3%)和 39.0%(95%CI:18.9%至 54.0%)。我们发现,mRNA 疫苗在家庭内对未接种儿童的间接效果小于对成年人的效果,且统计学上不显著。在这里,我们表明,在现实环境中,基于 mRNA 的 COVID-19 疫苗不仅能减少已接种个体的 SARS-CoV-2 感染,还能减少未接种成年家庭成员的感染。